SynBioBeta is the premier innovation network for innovators, investors, thinkers, and engineers »SynBioBeta is the premier innovation network for innovators, investors, thinkers, and engineers who share a passion for using synthetic biology to build a better, more sustainable universe. Follow this blog for stories of how synthetic biology will heal, fuel, feed, and build the future.
Nature Research is a portfolio of high-quality products and services across the life, physical, »Nature Research is a portfolio of high-quality products and services across the life, physical, chemical, and applied sciences, including journals, online databases and researcher services, which are dedicated to serving the scientific community. Follow this blog for the latest news and research on the topic of Synthetic biology.
In vitro synthesis of 32 translation-factor proteins from a single template reveals impaired ribosomal processivity 
Evolva launches L-arabinose, a natural sugar blocker and reducing sugar 
Twist Bioscience Signs Two Biopharma Technology Agreements to Enable Novel Therapeutics Discovery 
Yield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants 
IDT Developing PrimeTime™ SARS-CoV-2/Flu Test for Comprehensive Patient Testing 
Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors 
Characterizing the portability of phage-encoded homologous recombination proteins 
Sensing the future of bio-informational engineering 
Recombineering and MAGE 
Recombineering and MAGE